Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Albendazole pharmacokinetics in human cystic and alveolar echinococcosis
2022-003581-20Phase 4Active
- Sponsor
- Medical University of Vienna
- Start
- Feb 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of albendazole in cystic echinococcosis (CE) and Alveolar echinococcosis (AE), sponsored by Medical University of Vienna. Started Feb 2023; status: active.
02
Drugs
albendazole
03
Conditions
cystic echinococcosis (CE)Alveolar echinococcosis (AE)
Beyond the preview
Go deeper on 2022-003581-20.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2022-003581-20.